PDRN CareTypes of Collagen in Human Skin
Dr. Sarah Chen
PhD, Molecular Biology
Collagen is the most abundant structural protein in human skin, constituting approximately 70-80% of the dry weight of the dermis [1].
Definition
Collagen is the most abundant structural protein in human skin, constituting approximately 70-80% of the dry weight of the dermis [1]. The collagen superfamily comprises at least 28 genetically distinct types, but four types dominate skin biology: type I, type III, type IV, and type VII [1][5]. Each type has a unique structural role, and the balance among them determines skin firmness, elasticity, wound healing capacity, and resistance to aging.
Type I Collagen
Type I collagen is the principal structural collagen of the dermis, accounting for roughly 80% of total skin collagen in adults [1][2]. It forms thick, densely packed fibril bundles that provide tensile strength and mechanical resistance to the skin. Type I collagen is synthesized primarily by dermal fibroblasts as procollagen precursor molecules, which are enzymatically processed and assembled into mature fibrils in the extracellular space [1]. Age-related decline in type I collagen production is the primary driver of skin thinning, sagging, and wrinkle formation. After age 20, dermal collagen content decreases by approximately 1% per year, with type I collagen bearing the greatest absolute loss [2].
Type III Collagen
Type III collagen is the second most abundant collagen in skin, comprising approximately 15-20% of dermal collagen [1]. It forms thinner, more loosely organized fibrils compared to type I and is especially prevalent in young skin, giving it the designation of "youthful collagen." Type III collagen is also the dominant collagen in early wound healing, forming the initial provisional matrix that is gradually replaced by type I collagen during scar maturation [5]. The ratio of type III to type I collagen is a reliable indicator of skin youth β fetal skin contains up to 50% type III collagen, while aged adult skin may contain as little as 10% [1][2]. Treatments that restore type III collagen production are therefore of particular interest in anti-aging dermatology.
Type IV Collagen
Type IV collagen is a non-fibrillar collagen that forms the primary structural scaffold of the basement membrane, the thin specialized layer separating the epidermis from the dermis [1]. Unlike fibrillar collagens I and III, type IV collagen assembles into a sheet-like network that anchors epidermal keratinocytes to the underlying dermis and regulates the passage of nutrients and signaling molecules between the two compartments [5]. Degradation of type IV collagen compromises dermal-epidermal junction integrity, contributing to skin fragility, blister formation, and the flattened rete ridge pattern characteristic of photoaged skin.
Type VII Collagen
Type VII collagen is the major component of anchoring fibrils, specialized structures that physically attach the basement membrane to the underlying papillary dermis [1]. These anchoring fibrils loop through the lamina densa and insert into anchoring plaques within the dermis, creating a mechanical bond that prevents the epidermis from separating during shear stress. Type VII collagen deficiency is the hallmark of dystrophic epidermolysis bullosa, a genetic blistering disorder, illustrating the critical importance of this collagen in skin structural integrity [5].
How PDRN Stimulates Collagen Production
PDRN enhances collagen synthesis through activation of the adenosine A2A receptor on dermal fibroblasts [3][4]. A2A receptor engagement increases intracellular cAMP, which activates CREB-mediated transcription of collagen genes, particularly COL1A1 (type I) and COL3A1 (type III) [3]. Studies on PDRN-treated wound models demonstrate significant upregulation of both type I and type III procollagen expression within days of treatment, accompanied by measurable improvements in dermal thickness and tensile strength [4]. PDRN also provides the nucleotide building blocks β purine and pyrimidine bases β that proliferating fibroblasts require for DNA synthesis via the salvage pathway, removing a metabolic bottleneck that limits collagen production in aged or damaged tissue [3]. The combined effect of receptor-mediated signaling and substrate provision makes PDRN one of the most comprehensive collagen-stimulating strategies available, simultaneously enhancing fibroblast activity and supplying the raw materials those fibroblasts need to sustain elevated collagen output.
Clinical Significance
Understanding collagen types is essential for evaluating skin rejuvenation therapies. Effective anti-aging treatments should ideally stimulate both type I and type III collagen to restore dermal density and the youthful collagen ratio, while supporting type IV and type VII collagen to maintain dermal-epidermal junction integrity [1][2]. PDRN-based therapies address this requirement by activating the fundamental biological machinery of collagen synthesis rather than targeting a single collagen subtype, resulting in coordinated matrix renewal across all dermal layers [3][4].
References
- [1]Ricard-Blum S. The Collagen Family. Cold Spring Harb Perspect Biol. 2011;3(1):a004978. doi:10.1101/cshperspect.a004978
- [2]Varani J, Dame MK, Rittie L, et al.. Decreased Collagen Production in Chronologically Aged Skin: Roles of Age-Dependent Alteration in Fibroblast Function and Defective Mechanical Stimulation. Am J Pathol. 2006;168(6):1861-1868. doi:10.2353/ajpath.2006.051302
- [3]Squadrito F, Bitto A, Irrera N, et al.. Pharmacological Activity and Clinical Use of PDRN. Curr Pharm Des. 2017;23(27):3948-3957. doi:10.2174/1381612823666170516153716
- [4]Galeano M, Bitto A, Altavilla D, et al.. Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse. Wound Repair Regen. 2008;16(2):208-217. doi:10.1111/j.1524-475X.2008.00361.x
- [5]Sorushanova A, Delgado LM, Wu Z, et al.. The Collagen Suprafamily: From Biosynthesis to Advanced Biomaterial Development. Adv Mater. 2019;31(1):e1801651. doi:10.1002/adma.201801651